Structure |
Chemical Name |
CAS |
MF |
![Isavuconazole Impurity 37](/) |
Isavuconazole Impurity 37 |
|
|
![](/) |
"mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
![(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile](/) |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
![Mannitol EP impurity B](/) |
Mannitol EP impurity B |
|
|
![Mannitol EP impurity A](/) |
Mannitol EP impurity A |
|
|
![Peramivir Amino Carboxylic Isomerism Impurity](/) |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
![Peramivir Chlorinated Impurity](/) |
Peramivir Chlorinated Impurity |
|
|
![Brivaracetam Impurity 999](/) |
Brivaracetam Impurity 999 |
|
|
![Dasatinib impurity 48](/) |
Dasatinib impurity 48 |
|
|
![Pemetrexed Impurity 120](/) |
Pemetrexed Impurity 120 |
|
|
![Ticagrelor Impurity 101](/) |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
![(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate](/CAS/20180601/GIF/319924-73-7.gif) |
(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate |
319924-73-7 |
C10H17ClO4 |
![(R)-2-(2-aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide](/CAS/20180703/GIF/CB93955195.gif) |
(R)-2-(2-aminothiazol-4-yl)-N-(2-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide |
1684452-80-9 |
C21H24N4O2S |
![1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-[2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-ethyl Ester Hydrochloride](/CAS/20180703/GIF/210579-71-8.gif) |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-[2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl] 5-ethyl Ester Hydrochloride |
210579-71-8 |
C37H44ClN3O6 |
![2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde](/CAS/20180703/GIF/CB93955786.gif) |
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
2169267-53-0 |
C11H7ClFNO |
![4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one](/CAS/20180703/GIF/CB93955948.gif) |
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-99-9 |
C37H42F2N8O4 |
![Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)](/CAS/GIF/108928-81-0.gif) |
Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) |
108928-81-0 |
C25H37NO4 |
![N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]amine](/CAS/GIF/73278-98-5.gif) |
N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]amine |
73278-98-5 |
C15H24N2O |
![7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III](/CAS/GIF/95603-44-4.gif) |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III |
95603-44-4 |
C35H38Cl6O14 |
![4-(3-AMino-phenyl)-Morpholin-3-one](/CAS/GIF/1082495-22-4.gif) |
4-(3-AMino-phenyl)-Morpholin-3-one |
1082495-22-4 |
C10H12N2O2 |
![AlMotriptan Related CoMpound B](/CAS/20210111/GIF/1246860-65-0.gif) |
AlMotriptan Related CoMpound B |
1246860-65-0 |
C19H25N3O6S |
![Benazepril Related CoMpound B](/) |
Benazepril Related CoMpound B |
|
|
![IMatinib iMpurity](/CAS/20210111/GIF/152459-96-6.gif) |
IMatinib iMpurity |
152459-96-6 |
C24H21N5O |
![(2R,3R,4R,5S,6R)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](/CAS/20150408/GIF/CB92715716.gif) |
(2R,3R,4R,5S,6R)-2-(acetoxyMethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
|
C32H33FO9S |
![1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]-](/CAS/20150408/GIF/1365267-36-2.gif) |
1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
1365267-36-2 |
C36H36N6O10 |
![2-QuinazolineMethanol, 4-Methyl-](/CAS/20150408/GIF/13535-91-6.gif) |
2-QuinazolineMethanol, 4-Methyl- |
13535-91-6 |
C10H10N2O |
![5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one](/CAS/20150408/GIF/452340-96-4.gif) |
5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one |
452340-96-4 |
C13H15NO4 |
![alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride](/CAS/20150408/GIF/104743-23-9.gif) |
alpha-(Dimethylaminomethyl)-alpha-ethylbenzyl alcohol hydrochloride |
104743-23-9 |
C12H20ClNO |
![N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide](/CAS/20150408/GIF/177216-32-9.gif) |
N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide |
177216-32-9 |
C18H25N5O7 |
![5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1)](/CAS/20180808/GIF/64372-43-6.gif) |
5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) |
64372-43-6 |
C21H23BrFNO5 |
![(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine](/CAS/20150408/GIF/1070876-09-3.gif) |
(E)-2-Methyl-4-(4-(2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine |
1070876-09-3 |
C28H26N6S2 |
![(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate](/CAS/20150408/GIF/1187479-72-6.gif) |
(1S,2S,3R,5S)-PinanediolN-BOC-L-phenylalanine-L-leucine boronate |
1187479-72-6 |
C29H45BN2O5 |
![Posaconazole iMpurity 7](/CAS/20211123/GIF/2180759-84-4.gif) |
Posaconazole iMpurity 7 |
2180759-84-4 |
C37H42F2N8O4 |
![Intedanib Impurity](/CAS/20210305/GIF/2243396-74-7.gif) |
Intedanib Impurity |
2243396-74-7 |
C31H32N6O6 |
![5-(2-fluorophenyl)-N-methyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carboxamide](/CAS/20180703/GIF/CB93956046.gif) |
5-(2-fluorophenyl)-N-methyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carboxamide |
2054536-04-6 |
C17H14FN3O3S |
![Ozagrel Impurity 10](/) |
Ozagrel Impurity 10 |
|
|
![tris((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)amine](/CAS/20180703/GIF/CB93956556.gif) |
tris((5-(2-fluorophenyl)-1H-pyrrol-3-yl)methyl)amine |
|
C33H27F3N4 |
![Esmolol impurity C](/) |
Esmolol impurity C |
|
|
![CHLORHEXIDENE DIACETATE IMPURITY A](/CAS/GIF/152504-08-0.gif) |
CHLORHEXIDENE DIACETATE IMPURITY A |
152504-08-0 |
C16H24ClN9 |
![AZITHROMYCIN IMPURITY A](/) |
AZITHROMYCIN IMPURITY A |
|
|
![Bimatoprost Impurity 11](/) |
Bimatoprost Impurity 11 |
|
|
![Bimatoprost Impurity 9](/) |
Bimatoprost Impurity 9 |
|
|
![Dolutegravir Impurity 18](/) |
Dolutegravir Impurity 18 |
|
|
![PeraMpanel](/CAS/20210111/GIF/380918-53-6.gif) |
PeraMpanel |
380918-53-6 |
C23H15N3O |
![Lenvatinib Impurity 33](/) |
Lenvatinib Impurity 33 |
|
|
![isopropyl 2-(2-oxopyrrolidin-1-yl)acetate](/CAS/20210111/GIF/1249080-59-8.gif) |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
![Pitavastatin Impurity 71](/) |
Pitavastatin Impurity 71 |
|
|
![Rosuvastatin EP Impurity M Sodium Salt](/) |
Rosuvastatin EP Impurity M Sodium Salt |
|
|
![Furosemide impurity 8](/) |
Furosemide impurity 8 |
|
|
![Febuxostat Impurity 108](/) |
Febuxostat Impurity 108 |
|
|
![Flucloxacillin EP Impurity J](/) |
Flucloxacillin EP Impurity J |
|
|
![Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester](/CAS/20200611/GIF/1878175-77-9.gif) |
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
![AlviMopan iMpurity](/) |
AlviMopan iMpurity |
|
|
![Caspofungin iMpurity](/) |
Caspofungin iMpurity |
|
|
![Saxagliptin iMpurity](/CAS/20210111/GIF/2173146-35-3.gif) |
Saxagliptin iMpurity |
2173146-35-3 |
C18H24ClN3O2 |
![Chlorocriptine](/CAS/GIF/68944-88-7.gif) |
Chlorocriptine |
68944-88-7 |
C32H40ClN5O5 |
![PD 312237](/CAS/GIF/501666-23-5.gif) |
PD 312237 |
501666-23-5 |
C20H35NO11 |
![(1R,5S,6S)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Methyl Ester](/CAS/GIF/1234858-94-6.gif) |
(1R,5S,6S)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Methyl Ester |
1234858-94-6 |
C13H20O4 |
![Posaconazole DiastereoisoMer interMediate 5](/CAS/20180808/GIF/149809-42-7.gif) |
Posaconazole DiastereoisoMer interMediate 5 |
149809-42-7 |
C21H21F2N3O4S |
![Prasugrel alpha-Hydroxy IMpurity](/CAS/20150408/GIF/1100905-45-0.gif) |
Prasugrel alpha-Hydroxy IMpurity |
1100905-45-0 |
C11H11FO2 |
![Solifenacin Related CoMpound 2 Succinate](/CAS/20211123/GIF/1262506-09-1.gif) |
Solifenacin Related CoMpound 2 Succinate |
1262506-09-1 |
C27H32N2O6 |
![Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester](/CAS/20200611/GIF/480450-85-9.gif) |
Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester |
480450-85-9 |
C21H31N5O5S |
![3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)-](/CAS/20211123/GIF/1193817-52-5.gif) |
3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- |
1193817-52-5 |
C33H35FN2O7 |
![Hexanoic acid, 3-formyl-, ethyl ester](/CAS/20200611/GIF/54374-02-6.gif) |
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-](/CAS/20200611/GIF/154877-92-6.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2463617-49-2.gif) |
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](/CAS/20210111/GIF/906673-43-6.gif) |
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
![Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy-](/CAS/20211123/GIF/2417213-71-7.gif) |
Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy- |
2417213-71-7 |
C22H32N2O6S |
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](/CAS/20210111/GIF/1651211-78-7.gif) |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
![(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/) |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
![(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide](/) |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
![Aprepitant impurity 2](/) |
Aprepitant impurity 2 |
|
|
![Aprepitant impurity 4](/) |
Aprepitant impurity 4 |
|
|
![Vonoprazan Impurity B-2](/) |
Vonoprazan Impurity B-2 |
|
|
![2-(Cyanomethylthio)acetic acid](/CAS/GIF/55817-29-3.gif) |
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
![2(1H)-Pyridinone, 1-(3-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-](/CAS/20210111/GIF/2437650-75-2.gif) |
2(1H)-Pyridinone, 1-(3-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)- |
2437650-75-2 |
C15H19N3O2 |
![4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl-](/CAS/20210111/GIF/2512216-37-2.gif) |
4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl- |
2512216-37-2 |
C16H17N3O2 |
![Budesonide Impurity 31](/) |
Budesonide Impurity 31 |
|
|
![Budesonide Impurity 23](/) |
Budesonide Impurity 23 |
|
|
![Hexanoic acid, 3-(chloromethyl)-, (3R)-](/CAS/20210111/GIF/2101641-90-9.gif) |
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
![Bisoprolol Impurity](/CAS/20210305/GIF/2226263-68-7.gif) |
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
![2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)-](/CAS/20210111/GIF/1261219-83-3.gif) |
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
![Tofacitinib Impurity](/CAS/20211123/GIF/2504210-41-5.gif) |
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
![tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate](/) |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
![Avatrombopag Impurity 38](/) |
Avatrombopag Impurity 38 |
|
|
![(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)](/CAS/20211123/GIF/96946-55-3.gif) |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
![Glycine, N-(2-aminobenzoyl)-, ethyl ester](/CAS/20210305/GIF/5973-34-2.gif) |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxanine-8-carboxylic acid](/CAS/GIF/123040-79-9.gif) |
6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxanine-8-carboxylic acid |
123040-79-9 |
C10H8ClNO4 |
![3-Amino-3-azabicyclo[3.3.0]octane](/CAS/GIF/54528-00-6.gif) |
3-Amino-3-azabicyclo[3.3.0]octane |
54528-00-6 |
C7H14N2 |
![(S)-Methyl 2-aminobutanoate](/CAS/GIF/15399-22-1.gif) |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](/) |
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
![(3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione](/CAS/GIF/28092-52-6.gif) |
(3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione |
28092-52-6 |
C19H18N2O2S |
![methyl L-prolinate](/CAS/GIF/2577-48-2.gif) |
methyl L-prolinate |
2577-48-2 |
C6H11NO2 |
![sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate](/) |
sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |
|
|
![3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one](/) |
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
![2,4,6-tripropyl-1,3,5-trioxane](/CAS/GIF/2396-43-2.gif) |
2,4,6-tripropyl-1,3,5-trioxane |
2396-43-2 |
C12H24O3 |